This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Cautions/contra-indications

Authoring team

Contra-indications to ACE inhibitors:

  • hypersensitivity to ACE inhibitors including angioedema
  • known or suspected renovascular disease:
    • ACEI's should be used with caution in patients with peripheral vascular disease who may have clinically covert renovascular disease
    • significant bilateral renal artery stenosis or renal artery stenosis in a single functioning kidney (1)
  • pregnancy
    • lower fetal & neonatal blood pressure
    • impair renal function
    • can cause oligohydramnios and skull defects

Cautions include:

  • ACE inhibition in patients receiving diuretics
  • patients with peripheral vascular disease or generalised atherosclerosis (risk of covert renovascular disease)
  • risk of agranulocytosis is increased in patients with collagent vascular disease (monitoring of blood counts recommended)
  • symptomatic aortic stenosis
  • history of idiopathic or hereditary angioedema
  • renal impairment

Please check Summary of Product Characteristics before prescribing ACE inhibitor.

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.